These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35131527)

  • 1. Modeling the cellular fate of alpha-synuclein aggregates: A pathway to pathology.
    Marotta NP; Lee VM
    Curr Opin Neurobiol; 2022 Feb; 72():171-177. PubMed ID: 35131527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.
    Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P
    Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation.
    Mezias C; Rey N; Brundin P; Raj A
    Neurobiol Dis; 2020 Feb; 134():104623. PubMed ID: 31628991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation and propagation of α-synuclein aggregation in the nervous system.
    Hijaz BA; Volpicelli-Daley LA
    Mol Neurodegener; 2020 Mar; 15(1):19. PubMed ID: 32143659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion-like propagation of pathology in Parkinson disease.
    Volpicelli-Daley L; Brundin P
    Handb Clin Neurol; 2018; 153():321-335. PubMed ID: 29887143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Where and how alpha-synuclein pathology spreads in Parkinson's disease.
    Wakabayashi K
    Neuropathology; 2020 Oct; 40(5):415-425. PubMed ID: 32750743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology of α-synuclein propagation and braak hypothesis.
    McCann H; Cartwright H; Halliday GM
    Mov Disord; 2016 Feb; 31(2):152-60. PubMed ID: 26340605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prying into the Prion Hypothesis for Parkinson's Disease.
    Brundin P; Melki R
    J Neurosci; 2017 Oct; 37(41):9808-9818. PubMed ID: 29021298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
    Hansen C; Li JY
    Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The central theme of Parkinson's disease: α-synuclein.
    Ozansoy M; Başak AN
    Mol Neurobiol; 2013 Apr; 47(2):460-5. PubMed ID: 23180276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spreading of alpha-synuclein - relevant or epiphenomenon?
    Killinger BA; Kordower JH
    J Neurochem; 2019 Sep; 150(5):605-611. PubMed ID: 31152606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease.
    He Y; Yu Z; Chen S
    ACS Chem Neurosci; 2019 Feb; 10(2):777-782. PubMed ID: 30183251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats.
    Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P
    Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
    Zheng T; Zhang Z
    Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
    J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pericytes degrade diverse α-synuclein aggregates.
    Dieriks BV; Highet B; Alik A; Bellande T; Stevenson TJ; Low V; Park TI; Correia J; Schweder P; Faull RLM; Melki R; Curtis MA; Dragunow M
    PLoS One; 2022; 17(11):e0277658. PubMed ID: 36399706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optogenetic-mediated induction and monitoring of α-synuclein aggregation in cellular models of Parkinson's disease.
    Teixeira M; Sheta R; Idi W; Oueslati A
    STAR Protoc; 2023 Dec; 4(4):102738. PubMed ID: 37991922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.